— Stryker (NYSE: SYK) reported third-quarter 2019 earnings of $1.91 per share, vs. $1.90 per share expected.
— Total revenue grew 10.6% to $3.58 billion, in line with the street estimate. Organic sale grew 8.6% in Q3. Orthopaedics net sales of $1.3 billion increased 7.8% YoY.
— 2019 organic net sales growth expected near the higher end of the outlook range of 7.5% to 8.0%.
— Adjusted EPS for 2019 expected in the range of $8.20 to $8.25, and for the fourth quarter between $2.43 and $2.48.
— SYK shares have gained 43% since the beginning of this year.